315 related articles for article (PubMed ID: 20470425)
1. Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.
Stubbert LJ; Smith JM; McKay BC
BMC Cancer; 2010 May; 10():207. PubMed ID: 20470425
[TBL] [Abstract][Full Text] [Related]
2. CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29.
Yang Z; Liu C; Wu H; Xie Y; Gao H; Zhang X
BMC Cancer; 2019 Oct; 19(1):948. PubMed ID: 31615563
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal Region and SUMOylation of Cockayne Syndrome Group B Protein Play Critical Roles in Transcription-coupled Nucleotide Excision Repair.
Sin Y; Tanaka K; Saijo M
J Biol Chem; 2016 Jan; 291(3):1387-97. PubMed ID: 26620705
[TBL] [Abstract][Full Text] [Related]
4. RNA interference against transcription elongation factor SII does not support its role in transcription-coupled nucleotide excision repair.
Mackinnon-Roy C; Stubbert LJ; McKay BC
Mutat Res; 2011 Jan; 706(1-2):53-8. PubMed ID: 21070792
[TBL] [Abstract][Full Text] [Related]
5. UV light-induced degradation of RNA polymerase II is dependent on the Cockayne's syndrome A and B proteins but not p53 or MLH1.
McKay BC; Chen F; Clarke ST; Wiggin HE; Harley LM; Ljungman M
Mutat Res; 2001 Mar; 485(2):93-105. PubMed ID: 11182541
[TBL] [Abstract][Full Text] [Related]
6. Contributions of nucleotide excision repair, DNA polymerase eta, and homologous recombination to replication of UV-irradiated herpes simplex virus type 1.
Muylaert I; Elias P
J Biol Chem; 2010 Apr; 285(18):13761-8. PubMed ID: 20215648
[TBL] [Abstract][Full Text] [Related]
7. Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts.
Guillermo-Lagae R; Deep G; Ting H; Agarwal C; Agarwal R
Oncotarget; 2015 Nov; 6(37):39594-606. PubMed ID: 26447614
[TBL] [Abstract][Full Text] [Related]
8. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
[TBL] [Abstract][Full Text] [Related]
9. Von Hippel-Lindau-coupled and transcription-coupled nucleotide excision repair-dependent degradation of RNA polymerase II in response to trabectedin.
Aune GJ; Takagi K; Sordet O; Guirouilh-Barbat J; Antony S; Bohr VA; Pommier Y
Clin Cancer Res; 2008 Oct; 14(20):6449-55. PubMed ID: 18927284
[TBL] [Abstract][Full Text] [Related]
10. MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxal.
Fedier A; Poyet C; Perucchini D; Boulikas T; Fink D
Anticancer Drugs; 2006 Mar; 17(3):315-23. PubMed ID: 16520660
[TBL] [Abstract][Full Text] [Related]
11. Transcription-coupled nucleotide excision repair is coordinated by ubiquitin and SUMO in response to ultraviolet irradiation.
Liebelt F; Schimmel J; Verlaan-de Vries M; Klemann E; van Royen ME; van der Weegen Y; Luijsterburg MS; Mullenders LH; Pines A; Vermeulen W; Vertegaal ACO
Nucleic Acids Res; 2020 Jan; 48(1):231-248. PubMed ID: 31722399
[TBL] [Abstract][Full Text] [Related]
12. P53 plays a protective role against UV- and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblasts.
McKay BC; Becerril C; Ljungman M
Oncogene; 2001 Oct; 20(46):6805-8. PubMed ID: 11709715
[TBL] [Abstract][Full Text] [Related]
13. DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance.
Lin X; Howell SB
Mol Cancer Ther; 2006 May; 5(5):1239-47. PubMed ID: 16731756
[TBL] [Abstract][Full Text] [Related]
14. Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts.
de Waard H; Sonneveld E; de Wit J; Esveldt-van Lange R; Hoeijmakers JH; Vrieling H; van der Horst GT
DNA Repair (Amst); 2008 Oct; 7(10):1659-69. PubMed ID: 18634906
[TBL] [Abstract][Full Text] [Related]
15. Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.
Rainey RN; Ng SY; Llamas J; van der Horst GT; Segil N
J Neurosci; 2016 Apr; 36(17):4758-70. PubMed ID: 27122034
[TBL] [Abstract][Full Text] [Related]
16. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
17. The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells.
Perego P; Gatti L; Caserini C; Supino R; Colangelo D; Leone R; Spinelli S; Farrell N; Zunino F
J Inorg Biochem; 1999 Oct; 77(1-2):59-64. PubMed ID: 10626355
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells.
Branch P; Masson M; Aquilina G; Bignami M; Karran P
Oncogene; 2000 Jun; 19(28):3138-45. PubMed ID: 10918568
[TBL] [Abstract][Full Text] [Related]
19. Valosin-containing Protein (VCP)/p97 Segregase Mediates Proteolytic Processing of Cockayne Syndrome Group B (CSB) in Damaged Chromatin.
He J; Zhu Q; Wani G; Sharma N; Wani AA
J Biol Chem; 2016 Apr; 291(14):7396-408. PubMed ID: 26826127
[TBL] [Abstract][Full Text] [Related]
20. Presence of MLH1 protein aggravates the potential of the HSP90 inhibitor radicicol to sensitize tumor cells to cisplatin.
Fedier A; Stuedli A; Fink D
Int J Oncol; 2005 Dec; 27(6):1697-705. PubMed ID: 16273226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
